Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal ...

Refrigerated foods continue to gain traction in today’s market, driven by rising demand for freshness, convenience, and ...

Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

PwC and SAP join forces to optimise financial tech solutions, enhancing digital transformation and maximising ROI ...

Cytiva demonstrates that manufacturers must expand their focus to include strategic liquid planning for scale-up.

The Airborne Reconnaissance and Electronic Warfare System (ARES) is an aerial-intelligence, surveillance and reconnaissance aircraft that Army is contracting as a service to test which airframes will ...

New Trump-backed SPAC deal creates Trump Media Group CRO Strategy, funded by $1 billion in CRO tokens, cash, warrants and a $5 billion credit line from Yorkville affiliate. Trump Media and Technology ...

New framework expected on Friday Pandemic inflation surge made 2020 approach obsolete Policymakers searching for a more general approach JACKSON, Wyoming, Aug 21 (Reuters) - The U.S. Federal Reserve's ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. It’s understandable if you’re tempted to load up on the ...

Lantheus' new formulation of piflufolastat F 18 aims to increase batch size by 50% and enhance radioactive concentration, potentially expanding patient access. The original formulation was approved in ...

XCOM: Enemy Unknown offers challenging gameplay with rewarding combat encounters. Thronefall combines tower defense with real-time strategy in a minimalistic way. Slay The Spire is a modern classic ...

FDA accepts a new formulation of piflufolastat F 18, enhancing prostate cancer imaging access and efficiency, with a target action date of March 2026. The US FDA has accepted a New Drug Application ...